Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Carroll

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
Molecular Oncology|August 18, 2018
A patient-derived explant (PDE) model of hormone-dependent cancerMargaret M Centenera, Theresa E Hickey, Shalini Jindal, et al.
Cancer Cell|July 18, 2020
IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer MetastasisRasmus Siersbæk, Valentina Scabia, Sankari Nagarajan, et al.
Nature Genetics|January 9, 2020
ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment responseSankari Nagarajan, Shalini V Rao, Joseph Sutton, et al.
EMBO Molecular Medicine|February 22, 2011
ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epitheliumDaniel G Holland, Angela Burleigh, Anna Git, et al.
Nature Genetics|February 2, 2020
Author Correction: ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment responseSankari Nagarajan, Shalini V Rao, Joseph Sutton, et al.
Cell Reports|November 21, 2024
ZBTB7A is a modulator of KDM5-driven transcriptional networks in basal breast cancerBenedetto DiCiaccio, Marco Seehawer, Zheqi Li, et al.
Oncogene|January 9, 2021
Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotypeDamir Varešlija, Elspeth Ward, Siobhan P Purcell, et al.
Nature Medicine|January 19, 2021
The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancerTheresa E Hickey, Luke A Selth, Kee Ming Chia, et al.
Nature Cancer|January 6, 2026
Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trialRebecca A Burrell, Sanjeev Kumar, Elena Provenzano, et al.
Nature|August 7, 2015
Corrigendum: Progesterone receptor modulates ERα action in breast cancerHisham Mohammed, I Alasdair Russell, Rory Stark, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
Molecular Oncology|August 18, 2018
A patient-derived explant (PDE) model of hormone-dependent cancerMargaret M Centenera, Theresa E Hickey, Shalini Jindal, et al.
Cancer Cell|July 18, 2020
IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer MetastasisRasmus Siersbæk, Valentina Scabia, Sankari Nagarajan, et al.
Nature Genetics|January 9, 2020
ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment responseSankari Nagarajan, Shalini V Rao, Joseph Sutton, et al.
EMBO Molecular Medicine|February 22, 2011
ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epitheliumDaniel G Holland, Angela Burleigh, Anna Git, et al.
Nature Genetics|February 2, 2020
Author Correction: ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment responseSankari Nagarajan, Shalini V Rao, Joseph Sutton, et al.
Cell Reports|November 21, 2024
ZBTB7A is a modulator of KDM5-driven transcriptional networks in basal breast cancerBenedetto DiCiaccio, Marco Seehawer, Zheqi Li, et al.
Oncogene|January 9, 2021
Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotypeDamir Varešlija, Elspeth Ward, Siobhan P Purcell, et al.
Nature Medicine|January 19, 2021
The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancerTheresa E Hickey, Luke A Selth, Kee Ming Chia, et al.
Nature Cancer|January 6, 2026
Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trialRebecca A Burrell, Sanjeev Kumar, Elena Provenzano, et al.
Nature|August 7, 2015
Corrigendum: Progesterone receptor modulates ERα action in breast cancerHisham Mohammed, I Alasdair Russell, Rory Stark, et al.
Pageof 20